002880 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shenzhen Weiguang Biological Products Co., Ltd. engages in the manufacturing, research and development of drug and blood products. Its products include human albumin, human immunoglobulin, human hepatitis B immunoglobulin, human rabies immunoglobulin, tetanus immunoglobulin and histamine human immunoglobulin. The company was founded on October 22, 2001 and is headquartered in Shenzhen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
002880 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company